Top Injectable Manufacturer in Jordan – Reliable Pharmaceutical Solutions
- Maulik Sudani
- 3 days ago
- 7 min read
Last Updated: August 23, 2026
TL;DR: Jordan regulates medicines through the Jordan Food and Drug Administration (JFDA), established in 2003 under the Ministry of Health, which registers pharmaceutical products in CTD format, licenses importers, manufacturers and wholesalers, and has applied for PIC/S membership (application filed January 2021, rapporteurs appointed 2022). Public-sector pharmaceutical purchasing runs primarily through the Joint Procurement Department (JPD, formed 2005), which buys medicines and medical devices on behalf of the Ministry of Health hospital network, the Jordanian Royal Medical Services (RMS) military hospitals, and university hospitals such as King Abdullah University Hospital. Jordan is a member of the Hague Conference on Private International Law but has not acceded to the 1961 Apostille Convention, so Certificates of Pharmaceutical Product and GMP certificates from India require full consular/embassy legalization rather than an apostille. The country carries a heavy and rising non-communicable disease burden — the Middle East & North Africa region has the highest diabetes prevalence of any IDF Diabetes Atlas region at 17.6%, and Jordan's own modeled type-2 diabetes prevalence was estimated near 16% in 2020, projected toward 20.6% by 2050 — compounded by the healthcare needs of a large Syrian refugee population, among whom hypertension and diabetes are especially prevalent. Farbe Firma, a WHO-GMP certified sterile injectable manufacturer in Gujarat, India producing 100+ injectable products under ISO Class 5 aseptic conditions and exporting to 30+ countries, supports Jordanian importers and institutional buyers with CTD/ACTD-ready documentation built around JFDA's and JPD's requirements.
Key Takeaways
The Jordan Food and Drug Administration (JFDA), established in 2003 under the Ministry of Health, registers pharmaceutical products, licenses importers, manufacturers and wholesalers, sets pricing, and runs post-marketing surveillance; it accepts CTD-format dossiers and has applied for full PIC/S membership (application filed January 2021, with rapporteurs appointed in 2022), reflecting a system actively converging with recognized international standards. Farbe Firma structures its regulatory submissions in CTD format to match JFDA's accepted dossier structure directly.
We could not confirm a current, published WHO Global Benchmarking Tool maturity level for the JFDA and have not stated one here. Most Jordanian public-sector pharmaceutical purchasing is centralized through the Joint Procurement Department (JPD), formed in 2005, which buys on behalf of Ministry of Health hospitals, the Royal Medical Services (RMS) military hospital network, and university hospitals such as King Abdullah University Hospital and Jordan University Hospital — a tender-driven, institutional buying pattern importers need to plan around from the outset.
Jordan is a member of the Hague Conference on Private International Law but has not acceded to the 1961 Apostille Convention, so Certificates of Pharmaceutical Product, GMP certificates and other documents from India must go through full consular/embassy legalization instead of the faster apostille route available in many other markets Farbe Firma serves — a lead-time factor we build into every Jordan-bound registration timeline.
Jordan's non-communicable disease burden is substantial and still climbing: the Middle East & North Africa region already has the highest diabetes prevalence of any IDF Diabetes Atlas region at 17.6%, with Jordan-specific modeling projecting a rise from roughly 16% in 2020 toward 20.6% by 2050, while hypertension and diabetes are also especially prevalent among the country's large Syrian refugee population, keeping demand high for insulin and cardiovascular injectables alongside the antibiotics and critical-care products used across Jordan's hospital network.
Introduction: Why an Injectable Manufacturer in Jordan Must Meet Global Standards
Jordan sits at a crossroads of steady institutional demand and rising non-communicable disease pressure, and both push in the same direction: the country needs an injectable manufacturer in Jordan that can satisfy the Jordan Food and Drug Administration's CTD-format registration process while also meeting the volume and reliability expectations of a healthcare system built around large, centralized tenders. With around 106 hospitals serving the domestic population and roughly 250,000 medical-tourism patients arriving from neighboring countries annually, and healthcare expenditure running among the highest in the region, Jordan's public and private buyers alike are looking for manufacturing partners who can document quality rigorously and deliver at scale.
Farbe Firma Pvt Ltd, operating from Gujarat, India as a WHO-GMP certified sterile injectable manufacturer, produces more than 100 injectable formulations inside ISO Class 5 aseptic filling suites and exports to more than 30 countries under CTD and ACTD dossier formats. Serving Jordan well means preparing documentation the JFDA can process efficiently, understanding that Joint Procurement Department tenders reward manufacturers who can commit to consistent volumes and lead times, and planning for full consular legalization of Indian certificates since Jordan has not joined the Apostille Convention. Farbe Firma builds its Jordan engagement around all three realities at once rather than treating them as separate problems.
What Sets a World-Class Injectable Manufacturer in Jordan Apart
Any credible injectable manufacturer in Jordan has to work through the JFDA's registration pathway, which accepts CTD-format submissions covering quality, safety and efficacy data — manufacturing process descriptions, raw-material specifications, stability studies and GMP compliance evidence, alongside clinical data supporting the product's safety and efficacy profile. The JFDA also licenses the pharmaceutical importers who bring products into the country, so Farbe Firma works closely with its Jordanian import partners to keep licensing and product dossiers aligned rather than treating them as two separate workstreams.
Beyond registration, winning and keeping business in Jordan usually runs through the Joint Procurement Department, which centralizes purchasing for the Ministry of Health hospital network, the Royal Medical Services' military hospitals, and major university hospitals. JPD's tender-driven model rewards manufacturers who can back up a bid with dependable batch-to-batch consistency and realistic delivery commitments — exactly the kind of track record Farbe Firma has built exporting to more than 30 countries — and the JFDA's own progress toward PIC/S membership signals a regulatory environment actively converging with the standards Farbe Firma's quality systems are already built around.
Quality Systems Behind Every Batch We Ship to Jordan
Every batch leaving Farbe Firma's Gujarat facility for Jordan passes through the same analytical panel we apply globally. Identity, assay and related-substance testing run on validated HPLC and GC methods benchmarked against USP, BP, IP and EP monographs, Karl Fischer titration confirms residual moisture in lyophilized and powder-fill products, and every sterile lot undergoes sterility testing and bacterial endotoxin (LAL) testing, alongside sub-visible particulate counts, pH, osmolality and fill-volume verification. This is the certificate-of-analysis and validation documentation JFDA reviewers expect to see referenced in a CTD-format dossier, and that Joint Procurement Department technical evaluators typically request during tender due diligence.
Stability data is generated under ICH Q1A(R2) long-term and accelerated conditions, with photostability assessed per ICH Q1B, so shelf-life claims hold up under Jordan's hot, arid climate and the realities of institutional distribution across a hospital network that spans the country. Farbe Firma's export documentation is prepared in CTD format from the outset, which shortens the path through JFDA review, and our regulatory team builds full consular/embassy legalization lead time into every Jordan timeline from the start, since no apostille shortcut is available for Indian-issued certificates.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in Jordan for Global Buyers
Jordan's disease burden creates specific, sustained injectable demand. The Middle East & North Africa region already carries the highest diabetes prevalence of any IDF Diabetes Atlas region at 17.6%, and Jordan's own modeled type-2 diabetes prevalence is projected to climb from roughly 16% in 2020 toward 20.6% by 2050, keeping insulin and related injectables in steady, growing demand. Hypertension and diabetes are also especially prevalent among Jordan's large Syrian refugee population — clinical studies in northern Jordan have found hypertension affecting well over a quarter of surveyed refugee patients — adding further pressure on cardiovascular and metabolic injectable therapies delivered through Ministry of Health and NGO-supported clinics alike.
For manufacturers and brand owners, Farbe Firma also functions as a CDMO/CMO partner, offering private-label sterile injectables built on the same WHO-GMP, ISO Class 5 platform, with CTD/ACTD-format technical files ready to support both JFDA registration and Joint Procurement Department tender due diligence. India remains one of Jordan's largest trading partners — bilateral trade reached roughly USD 2.875 billion in 2023-24 — and the two countries' health authorities held a Joint Working Group session in September 2025 covering pharmaceuticals, vaccines, medical devices and non-communicable disease cooperation, a policy backdrop that favors deeper Indian pharmaceutical engagement with Jordan's market.
In practice, succeeding in Jordan means treating JFDA registration, JPD tender readiness and consular legalization lead time as one integrated timeline rather than three separate hurdles. Farbe Firma's export team prepares CTD dossiers built for JFDA review, keeps documentation ready for Joint Procurement Department technical evaluation, and factors full embassy legalization into every quote and delivery schedule from the outset, so Jordanian importers and institutional buyers get a realistic, dependable timeline rather than one that assumes shortcuts Jordan's regulatory framework doesn't offer.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified injectable manufacturer for Jordan?
Yes. Farbe Firma is a WHO-GMP certified sterile injectable manufacturer based in Gujarat, India, operating ISO Class 5 aseptic filling lines and producing more than 100 injectable products for export to over 30 countries. Our documentation is prepared in CTD and ACTD formats to support both Jordan Food and Drug Administration (JFDA) registration and Joint Procurement Department tender requirements.
How does injectable product registration work in Jordan?
The Jordan Food and Drug Administration (JFDA), established in 2003 under the Ministry of Health, registers pharmaceutical products using CTD-format dossiers covering quality, safety and efficacy data, including manufacturing process details, stability studies and GMP compliance evidence. The JFDA also licenses the importers who bring registered products into the country.
Do we need a local partner or agent to sell injectables in Jordan?
Yes. JFDA-licensed local importers are required to bring pharmaceutical products into Jordan, and for institutional business, that partner's experience navigating Joint Procurement Department tenders — which supply the Ministry of Health hospital network, Royal Medical Services and university hospitals — matters as much as their registration experience. Farbe Firma works closely with its Jordanian import partners on both fronts.
Which injectables are in strongest demand in Jordan?
Given Jordan's rising diabetes prevalence — among the highest of any IDF Diabetes Atlas region regionally — insulin and metabolic injectables are in steady demand, alongside cardiovascular injectables driven by high hypertension rates, particularly among the country's large Syrian refugee population. Broader hospital-network demand for injectable antibiotics and critical-care formulations remains strong as well, and Farbe Firma's 100+ product range covers all of these categories.
What documentation and logistics considerations matter most for a Jordan launch?
Because Jordan has not acceded to the 1961 Apostille Convention, Certificates of Pharmaceutical Product and GMP certificates from India require full consular/embassy legalization, which takes longer than an apostille — build that into your timeline. On the commercial side, plan around the Joint Procurement Department's centralized, tender-driven purchasing model for public-sector business, since it rewards manufacturers who can commit to consistent volumes and dependable delivery.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments